Lessons learned from the development of the CancerLinQ prototype: Clinical decision support.

Authors

Richard L. Schilsky

Richard L. Schilsky

American Society of Clinical Oncology, Alexandria, VA

Richard L. Schilsky, Sandra M. Swain, Robert Hauser, Joshua Mann, George W. Sledge, Peter Paul Yu, Allen S. Lichter, Clifford Hudis

Organizations

American Society of Clinical Oncology, Alexandria, VA, MedStar Washington Hospital Center, Washington, DC, Stanford University, Stanford, CA, Palo Alto Medical Foundation, Mountain View, CA, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Research Funding

No funding sources reported

Background: CancerLinQ (CLQ) is a rapid learning system (RLS) for oncology in development by ASCO. CLQ is based on the transfer of electronic health records (EHR) from participating oncology practices to a data warehouse where data aggregation and de-identification occurs. A prototype was built using open source software and has collected de-identified data on 170,000+ pts with breast cancer (BC) from 31 community oncology practices using 4 different EHRs. The primary goals for the prototype were 1. Aggregate patient data from any EHR platform, process it and create a longitudinal record; 2. Develop quality reports from EHRs; 3. Point of care Clinical Decision Support (CDS) from ASCO guidelines; 4. Data visualization for hypothesis generation; 5. Demonstrate desire to share data for quality improvement; 6. Describe lessons learned (LL). This report focuses on LL about CDS. Methods: Physician experts identified specific elements from each ASCO BC guideline to make machine readable (MR). Abstractors then GEM-cut the elements using the GEM Abstraction Manual and Style Guide. The output reports were reviewed for comprehensiveness, accuracy, and style. Following verification of the GEM-cut content, reports were sent for meta-tagging, done by selecting widely used EHR vocabulary from the Unified Medical Language System (UMLS). The GEM-cut output and meta-tags were converted to DROOLS syntax and the resulting coded files were inserted into the DROOLS rules engine. When the rules engine encounters a combination of facts that match a rule, that rule is presented to the user. The enduring responses are collected using ‘queries’ and the CDS results are delivered to the EHR. Results: Guidelines are often not written as “if”/“then” statements which is key for computer-based CDS. Any unintentional ambiguity must be removed for machine MR CDS. Using new methodologies, we have been able to convert narrative guidelines into MR CDS. Conclusions: Conversion of ASCO’s clinical guidelines into a MR format is possible. New and emerging methods such as GLIDES, BRIDGE-Wiz, and GEM-cutting provide excellent tools to migrate existing narrative recommendations into MR format that can populate CDS tools, such as those provided by CancerLinQ.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2013 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Practice of Quality and Health Reform

Track

Practice of Quality,Health Reform: Implications for Costs and Quality

Sub Track

Use of IT to Improve Quality

Citation

J Clin Oncol 31, 2013 (suppl 31; abstr 237)

Abstract #

237

Poster Bd #

E19

Abstract Disclosures

Similar Abstracts

First Author: Jianbin Li

First Author: Sujith Puskoor

Abstract

2023 ASCO Quality Care Symposium

Implementing a BRAF biomarker electronic clinical quality measure in CancerLinQ.

First Author: Caitlin Drumheller